Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

1.

The effect of long-term alendronate treatment on cortical thickness of the proximal femur.

Unnanuntana A, Ashfaq K, Ton QV, Kleimeyer JP, Lane JM.

Clin Orthop Relat Res. 2012 Jan;470(1):291-8. doi: 10.1007/s11999-011-1985-9. Epub 2011 Jul 20.

PMID:
21773861
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.

Napoli N, Jin J, Peters K, Wustrack R, Burch S, Chau A, Cauley J, Ensrud K, Kelly M, Black DM.

J Clin Endocrinol Metab. 2012 Jul;97(7):2414-22. doi: 10.1210/jc.2011-3256. Epub 2012 Apr 30.

PMID:
22547423
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM.

Osteoporos Int. 2009 Aug;20(8):1353-62. doi: 10.1007/s00198-008-0805-x. Epub 2008 Dec 9.

PMID:
19066707
[PubMed - indexed for MEDLINE]
4.

Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.

Ng YH, Gino PD, Lingaraj K, Das De S.

Injury. 2011 Jul;42(7):702-6. doi: 10.1016/j.injury.2010.12.019. Epub 2011 Feb 11.

PMID:
21316051
[PubMed - indexed for MEDLINE]
5.

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

Kwek EB, Goh SK, Koh JS, Png MA, Howe TS.

Injury. 2008 Feb;39(2):224-31. doi: 10.1016/j.injury.2007.08.036. Epub 2008 Jan 28.

PMID:
18222447
[PubMed - indexed for MEDLINE]
6.

Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.

Capeci CM, Tejwani NC.

J Bone Joint Surg Am. 2009 Nov;91(11):2556-61. doi: 10.2106/JBJS.H.01774.

PMID:
19884427
[PubMed - indexed for MEDLINE]
7.

Letter to the editor: the effect of long-term alendronate treatment on cortical thickness of the proximal femur.

Koh JS, Ng AC, Png MA, Howe TS.

Clin Orthop Relat Res. 2011 Dec;469(12):3509-10; author reply 3511-12. doi: 10.1007/s11999-011-2129-y. No abstract available.

PMID:
21997786
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Case reports: two femoral insufficiency fractures after long-term alendronate therapy.

Sayed-Noor AS, Sjödén GO.

Clin Orthop Relat Res. 2009 Jul;467(7):1921-6. doi: 10.1007/s11999-009-0725-x. Epub 2009 Feb 6.

PMID:
19198962
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Changes of femoral periprosthetic bone mineral density 6 years after treatment with alendronate following total hip arthroplasty.

Arabmotlagh M, Pilz M, Warzecha J, Rauschmann M.

J Orthop Res. 2009 Feb;27(2):183-8. doi: 10.1002/jor.20748.

PMID:
18752281
[PubMed - indexed for MEDLINE]
10.

Effects of 1 to 3 years' treatment with alendronate on mechanical properties of the femoral shaft in a canine model: implications for subtrochanteric femoral fracture risk.

Burr DB, Diab T, Koivunemi A, Koivunemi M, Allen MR.

J Orthop Res. 2009 Oct;27(10):1288-92. doi: 10.1002/jor.20895.

PMID:
19396816
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.

Pazianas M, Abrahamsen B, Wang Y, Russell RG.

Osteoporos Int. 2012 Dec;23(12):2873-84. doi: 10.1007/s00198-012-1952-7. Epub 2012 Mar 20.

PMID:
22431012
[PubMed - indexed for MEDLINE]
12.

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

Goh SK, Yang KY, Koh JS, Wong MK, Chua SY, Chua DT, Howe TS.

J Bone Joint Surg Br. 2007 Mar;89(3):349-53.

PMID:
17356148
[PubMed - indexed for MEDLINE]
Free Article
13.

Bilateral low-energy sequential femoral shaft fractures in patients on long-term bisphosphonate therapy.

Çakmak S, Mahiroğulları M, Keklikçi K, Sarı E, Erdik B, Rodop O.

Acta Orthop Traumatol Turc. 2013;47(3):162-72.

PMID:
23748615
[PubMed - indexed for MEDLINE]
Free Article
14.

A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.

Cross MB, Nam D, van der Meulen MC, Bostrom MP.

J Bone Joint Surg Br. 2012 Jul;94(7):994-7. doi: 10.1302/0301-620X.94B7.28778.

PMID:
22733959
[PubMed - indexed for MEDLINE]
15.

A rational approach to management of alendronate-related subtrochanteric fractures.

Das De S, Setiobudi T, Shen L, Das De S.

J Bone Joint Surg Br. 2010 May;92(5):679-86. doi: 10.1302/0301-620X.92B5.22941.

PMID:
20436006
[PubMed - indexed for MEDLINE]
16.

Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.

Ing-Lorenzini K, Desmeules J, Plachta O, Suva D, Dayer P, Peter R.

Drug Saf. 2009;32(9):775-85. doi: 10.2165/00002018-200932090-00002.

PMID:
19670917
[PubMed - indexed for MEDLINE]
17.

Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.

Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y.

J Bone Miner Metab. 2012 Sep;30(5):561-7. doi: 10.1007/s00774-012-0358-0. Epub 2012 May 19.

PMID:
22610061
[PubMed - indexed for MEDLINE]
18.

Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.

Li M, Zhang ZL, Liao EY, Chen DC, Liu J, Tao TZ, Wu W, Xia WB, Lu YJ, Sheng ZF, Lu CY, Meng GL, Xu L, Zhang WJ, Hu YY, Xu L.

Menopause. 2013 Jan;20(1):72-8. doi: 10.1097/gme.0b013e31825fe2e8.

PMID:
22968256
[PubMed - indexed for MEDLINE]
19.

Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis.

Abrahamsen B, Eiken P, Eastell R.

J Clin Endocrinol Metab. 2010 Dec;95(12):5258-65. doi: 10.1210/jc.2010-1571. Epub 2010 Sep 15.

PMID:
20843943
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Bilateral atypical femoral fractures after long-term alendronate therapy: a case report.

Bamrungsong T, Pongchaiyakul C.

J Med Assoc Thai. 2010 May;93(5):620-4.

PMID:
20524451
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk